Feed Preview

Cardiovascular Biology of GLP-1

Cardiovascular Biology of GLP-1 diagram by ibreakstock, Shutterstock
ibreakstock, Shutterstock

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Top 20 most recent papers
ACS Pharmacology & Translational Science

The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome

ACS Pharmacology & Translational ScienceMarch 29, 2020
Daniel J Drucker
The Journal of Clinical Endocrinology and Metabolism

Pheochromocytoma with Adrenergic Biochemical Phenotype Shows Decreased Glp-1 Secretion and Impaired Glucose Tolerance

The Journal of Clinical Endocrinology and MetabolismMarch 31, 2020
Ondřej PetrákMartin Haluzík
American Journal of Perinatology

Maternal Metabolic Biomarkers are Associated with Obesity and Excess Gestational Weight Gain

American Journal of PerinatologyApril 2, 2020
Kathleen M AntonyKjersti M Aagaard
JHEP Reports : Innovation in Hepatology

miR-22 inhibition reduces hepatic steatosis via FGF21 and FGFR1 induction

JHEP Reports : Innovation in HepatologyMarch 21, 2020
Ying HuYu-Jui Yvonne Wan
Frontiers in Endocrinology

Role of the Gut in Diabetic Dyslipidemia

Frontiers in EndocrinologyApril 2, 2020
Priska StahelGary F Lewis
Journal of Clinical Medicine

Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes

Journal of Clinical MedicineApril 1, 2020
Angelo Maria PattiFerdinando Mannello
Clinical Medicine Insights. Endocrinology and Diabetes

Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism

Clinical Medicine Insights. Endocrinology and DiabetesApril 2, 2020
Natasha A TrzaskalskiErin E Mulvihill
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders

Once-Weekly Semaglutide Reduces HbA1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Common OAD: a Subgroup Analysis from SUSTAIN 2-4 and 10

Diabetes Therapy : Research, Treatment and Education of Diabetes and Related DisordersMarch 21, 2020
Matthew CapehornEsteban Jódar
Critical Reviews in Food Science and Nutrition

A systematic review and meta-analysis of medium-chain triglycerides effects on acute satiety and food intake

Critical Reviews in Food Science and NutritionMarch 28, 2020
Tyler Maher, Miriam E Clegg
The American Journal of Managed Care

Cost-effectiveness of diabetes treatment sequences to inform step therapy policies

The American Journal of Managed CareMarch 18, 2020
Anna HungJulia F Slejko

See more papers from this feed

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.


Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

© 2020 Meta ULC. All rights reserved